Valeant Pharmaceuticals International Inc. again boosted its takeover bid for botox maker Allergan Inc. to about $54 billion in cash and stock, subject to prompt good-faith discussions on a merger agreement.
from WSJ.com: US Business http://ift.tt/1nLvq9t
via IFTTT
from WSJ.com: US Business http://ift.tt/1nLvq9t
via IFTTT
No comments:
Post a Comment